10 results
425
EX-99.1
LGND
Ligand Pharmaceuticals Incorporated
21 Jun 22
Business combination disclosure
8:00am
yields greater immunogenicity and more antibody diversity POWERED BY EVOLUTION
29 HER2 ORTHOLOGUES H uman vs . C hicken (differences in green ) H uman
8-K
EX-99.1
LGND
Ligand Pharmaceuticals Incorporated
21 Jun 22
Regulation FD Disclosure
6:19am
yields greater immunogenicity and more antibody diversity POWERED BY EVOLUTION
29 HER2 ORTHOLOGUES H uman vs . C hicken (differences in green ) H uman
8-K
EX-10.1
gwt e2s4gidn2jc
9 Sep 11
Entry into a Material Definitive Agreement
12:00am
- Prev
- 1
- Next